Study finds insurance denials for brand-name drugs jumped 67 percent
A new study published in JAMA has found insurance denials for brand-name drugs without generic alternatives jumped 67 percent between 2018 and 2024.
A new study published in JAMA has found insurance denials for brand-name drugs without generic alternatives jumped 67 percent between 2018 and 2024.